EP Patent

EP1604667A1 — Opioids for the treatment of the restless leg syndrome

Assigned to Euro Celtique SA · Expires 2005-12-14 · 20y expired

What this patent protects

The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).

USPTO Abstract

The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with restless leg syndrome (RLS).

Drugs covered by this patent

hydrocodone-bitartrate (HYDROCODONE BITARTRATE)

Patent Metadata

Patent number: EP1604667A1
Jurisdiction: EP
Classification: —
Expires: 2005-12-14
Drug substance claim: No
Drug product claim: No
Assignee: Euro Celtique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.